Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (171-180 of 252) with videos related to

Pageof 26
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 15, 2015
Metals distribution in colorectal biopsies: New insight on the elemental fingerprint of tumour tissueLeslie Rinaldi, Gabriele Barabino, Jean-Philippe Klein, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 24, 2020
Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's diseaseMathilde Boube, David Laharie, Stéphane Nancey, et al.
Viruses|December 23, 2022
Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus ReactivationAlexandre Jentzer, Sébastien Fauteux-Daniel, Paul Verhoeven, et al.
Inflammatory Bowel Diseases|November 11, 2023
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter StudyRobert D Little, Adrian Swaine, Rebecca Reynolds, et al.
BMC Gastroenterology|December 2, 2022
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective studyCassandra Rayer, Maria Nachury, Arnaud Bourreille, et al.
BMC Gastroenterology|February 2, 2023
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective studyCassandra Rayer, Maria Nachury, Arnaud Bourreille, et al.
Alimentary Pharmacology & Therapeutics|April 19, 2021
Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel diseaseQuentin Tournier, Stephane Paul, Nicolas Williet, et al.
Oncotarget|February 4, 2017
The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarkerNicolas Williet, Carmen Adina Petcu, Leslie Rinaldi, et al.
Inflammatory Bowel Diseases|December 22, 2016
Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's DiseaseXavier Roblin, Gerard Duru, Nicolas Williet, et al.
Gut|January 26, 2020
Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trialXavier Roblin, Nicolas Williet, Gilles Boschetti, et al.
Pageof 26

Showing results (171-180 of 252) with videos related to

Sort By:
Pageof 26
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 15, 2015
Metals distribution in colorectal biopsies: New insight on the elemental fingerprint of tumour tissueLeslie Rinaldi, Gabriele Barabino, Jean-Philippe Klein, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 24, 2020
Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's diseaseMathilde Boube, David Laharie, Stéphane Nancey, et al.
Viruses|December 23, 2022
Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus ReactivationAlexandre Jentzer, Sébastien Fauteux-Daniel, Paul Verhoeven, et al.
Inflammatory Bowel Diseases|November 11, 2023
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter StudyRobert D Little, Adrian Swaine, Rebecca Reynolds, et al.
BMC Gastroenterology|December 2, 2022
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective studyCassandra Rayer, Maria Nachury, Arnaud Bourreille, et al.
BMC Gastroenterology|February 2, 2023
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective studyCassandra Rayer, Maria Nachury, Arnaud Bourreille, et al.
Alimentary Pharmacology & Therapeutics|April 19, 2021
Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel diseaseQuentin Tournier, Stephane Paul, Nicolas Williet, et al.
Oncotarget|February 4, 2017
The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarkerNicolas Williet, Carmen Adina Petcu, Leslie Rinaldi, et al.
Inflammatory Bowel Diseases|December 22, 2016
Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's DiseaseXavier Roblin, Gerard Duru, Nicolas Williet, et al.
Gut|January 26, 2020
Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trialXavier Roblin, Nicolas Williet, Gilles Boschetti, et al.
Pageof 26